SCHEMBL18565850

SCHEMBL18565850

CC1(C)c2ccccc2-c2cc(-c3ccc4c5ccccc5n(-c5cccc(-c6cc(-c7cccc(-n8c9ccccc9c9ccc(-c%10ccc%11c(c%10)-c%10ccccc%10C%11(C)C)cc98)c7)nc(-c7cccc(-n8c9ccccc9c9ccc(-c%10ccc%11c(c%10)-c%10ccccc%10C%11(C)C)cc98)c7)n6)c5)c4c3)ccc21

nearest known ligand 0.33

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ GLA P06280 1/20 0.32
▸ PDK2 Q15119 1/20 0.31
▸ ATM Q13315 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ FLT3 P36888 1/20 0.31
▸ BMX P51813 1/20 0.31
▸ PDE10A Q9Y233 1/20 0.30
▸ POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18565846 0.97 KDM4E (0.34) KDM4EALDH1A1MEN1LMNAMAPT
SCHEMBL18565847 0.96 KDM4E (0.33) KDM4EALDH1A1MEN1LMNAMAPT
SCHEMBL18565834 0.95 MEN1 (0.34) KDM4EALDH1A1MEN1LMNAMAPT
SCHEMBL18565872 0.95 PDK2 (0.33) KDM4EALDH1A1MEN1LMNAMAPT
SCHEMBL18565851 0.95 KDM4E (0.33) KDM4EATML3MBTL1PDE10A
SCHEMBL17879028 0.94 KDM4E (0.33) KDM4EALDH1A1MEN1LMNAMAPT
SCHEMBL18565860 0.92 KDM4E (0.32) KDM4EALDH1A1MEN1LMNAMAPT
SCHEMBL18565742 0.92 PDK2 (0.32) KDM4EALDH1A1MEN1LMNAMAPT
SCHEMBL18565845 0.92 KDM4E (0.33) KDM4EATML3MBTL1PDE10A
SCHEMBL18565841 0.92 KDM4E (0.33) KDM4EATML3MBTL1PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-05-14 — — US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 — — US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device EED, BMI1, CD99 KDM4E 225/4885ALDH1A1 2977/4885MEN1 1686/4885
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE EED, BMI1, CD99 KDM4E 225/4885ALDH1A1 2977/4885MEN1 1686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback